|
|
| | L-Cysteine, L-cysteinyl-L-alanylglycyl-L-arginyl-L-arginyl-L-seryl-L-alanyl-L-tyrosyl- Basic information |
| | L-Cysteine, L-cysteinyl-L-alanylglycyl-L-arginyl-L-arginyl-L-seryl-L-alanyl-L-tyrosyl- Chemical Properties |
| density | 1.57±0.1 g/cm3(Predicted) | | pka | 2.95±0.10(Predicted) | | Sequence | Cys-Ala-Gly-Arg-Arg-Ser-Ala-Tyr-Cys |
| | L-Cysteine, L-cysteinyl-L-alanylglycyl-L-arginyl-L-arginyl-L-seryl-L-alanyl-L-tyrosyl- Usage And Synthesis |
| Uses | AGR is a peptide. AGR recognizes lymphatic vessels in fully developed prostate tumors but not in the pre-malignant lesions[1]. | | References | [1] Le Joncour V, et al. Seek & Destroy, use of targeting peptides for cancer detection and drug delivery. Bioorg Med Chem. 2018 Jun 1;26(10):2797-2806. DOI:10.1016/j.bmc.2017.08.052 |
| | L-Cysteine, L-cysteinyl-L-alanylglycyl-L-arginyl-L-arginyl-L-seryl-L-alanyl-L-tyrosyl- Preparation Products And Raw materials |
|